• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Finance

Wall Street Welcomes Midterm Election Results with a Broad-Based Stock Rally

By
Kevin Kelleher
Kevin Kelleher
By
Kevin Kelleher
Kevin Kelleher
November 7, 2018, 7:02 PM ET

A day after one of the most tumultuous mid-term elections in recent memory, investors emerged in a buying mood, pushing both the Dow Jones Industrial Average and the S&P 500 Index up more than 2%.

The 2018 mid-term election campaign was one riven by a bitter partisan divide. Once the votes were tallied, Democrats retook the House of Representatives while Republicans strengthened their hold on the Senate. Wall Street seemed to take to a Congress split between parties, with most stocks on U.S. exchanges rallying the day after Election Day.

U.S. market indexes rallied on the news, with the Dow and S&P 500 both gaining 2.1% Wednesday, while the Nasdaq Composite gained 2.6%. In contrast to Red October, when investors fled riskier growth stocks like tech giants in favor of a handful of defensive sectors like retail and consumer goods, the post-election rally was strongest in tech, finance and even recently listed cannabis stocks.

Among financial-services stocks, MasterCard gained 4.6%, while Visa rose 2.8% and PayPal rose 4.2%. Amazon, one of the most beaten-down tech stocks in the past month, gained 6.9% today. Apple rose 3%, Google 3.6%, Microsoft 4% and Netflix 5.4%.

Some of the more actively traded cannabis stocks had their strongest days in a while. Tilray gained 31%, while Canopy Group rose 8.2% and Aurora Cannabis advanced 9.2%.

Not only did Michigan become the tenth state, and first state in the Midwest, to legalize recreational cannabis sales, but U.S. Attorney General Jeff Sessions resigned Wednesday at the request of President Trump. That alleviated some concern among investors in cannabis stocks that the Justice Department would counter local referendums that made pot legal in certain states.

Health-care stocks also rallied amid expectations that significant changes to the U.S. health system, which could harm their profits, were reduced after the mid-term elections. Pfizer rose 3.2%, while Merck gained 2.4% and UnitedHealth Group was up 4.2%.

About the Author
By Kevin Kelleher
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.